Medicenna Therapeutics Corp Stock Statistic Functions Linear Regression Angle

MDNA Stock  CAD 0.77  -0.03  -3.75%   
This statistic functions tool runs Linear Regression Angle function and companion studies for Medicenna Therapeutics. It emphasizes statistical functions describing dispersion and variability while keeping volatility, risk, and performance context in view.Enter Time Period to generate the indicator output.

Execute Function
This analysis covers thirty-eight data points across the selected time horizon. The Linear Regression Angle indicator plots the angel of the trend line for each Medicenna Therapeutics data point.

Medicenna Therapeutics Technical Analysis Modules

Most technical analysis of Medicenna Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Medicenna from various momentum indicators to cycle indicators. When you analyze Medicenna charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Stock Overview, Methodology & Data Sources

Medicenna Therapeutics Corp., a clinical stage immunotherapy company, develops and commercializes Empowered Cytokines and Superkines for the treatment of cancer. Medicenna Therapeutics Corp. is headquartered in Toronto, Canada. MEDICENNA THERAPEUTICS operates under Biotechnology classification in Canada and is traded on Toronto Stock Exchange. It employs 7 people. This stock section frames Medicenna Therapeutics within its peer set and highlights how fundamentals align with price behavior. Current metrics include P/B of 10.34. Medicenna Therapeutics has a market cap of 64.23 M, ROE of -109.78%.

Methodology

Unless otherwise specified, financial data for Medicenna Therapeutics Corp is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Medicenna (CA:MDNA) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Inputs are aggregated from public filings and market reference sources and public institutions such as U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Certain values may not reflect real-time changes. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Medicenna Therapeutics Corp may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.

This content is curated and reviewed by:

Ellen Johnson - Member of Macroaxis Editorial Board
Last reviewed on March 5th, 2026

Become your own money manager

Portfolio analytics tied to Medicenna Therapeutics Corp help investors review performance in context instead of judging the holding in isolation. Used properly, the workflow gives investors clearer signals on when to hold, resize, hedge, or replace the position.

Did you try this?

Run Share Portfolio Now

   

Share Portfolio

Track or share privately all of your investments from the convenience of any device
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Investor Favorites Idea
Investor Favorites
Invested few shares
Macroaxis Index Idea
Macroaxis Index
Invested over 60 shares
Driverless Cars Idea
Driverless Cars
Invested over 40 shares
Momentum Idea
Momentum
Invested few shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 20 shares
Advertising Idea
Advertising
Invested few shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
Dividend Beast Idea
Dividend Beast
Invested over 40 shares
Adviser Favorites Idea
Adviser Favorites
Invested few shares
Blockchain Idea
Blockchain
Invested few shares

More Resources for Medicenna Stock Analysis

Other Information on Investing in Medicenna Stock

Medicenna Therapeutics financial ratios help frame valuation context across profits, cash flow, and enterprise value. They help compare Medicenna across valuation measures in a consistent way.